Literature DB >> 24286979

Kidney Disease: Improving Global Outcomes--an update.

Bertram L Kasiske1, David C Wheeler.   

Abstract

Kidney Disease: Improving Global Outcomes (KDIGO) was founded in 2003 to fulfill a need for international cooperation and consolidation in the development and implementation of clinical practice guidelines. KDIGO has experienced a rapid growth in the development of guidelines, producing three guidelines in its first 6 years and another six in the last 3 years. In addition, it has held 12 global conferences on important issues in kidney disease and its treatment. A major effort is under way to support the dissemination and implementation of KDIGO guidelines through various channels, including an Implementation Task Force with official representatives in 86 countries. KDIGO is now under its own management and remains committed to the development of evidence-based guidelines. Future challenges include finding adequate sources of funding and building stronger links with other organizations involved in guideline development and implementation.

Entities:  

Keywords:  KDIGO; controversies conferences; guidelines; implementation; methodology

Mesh:

Year:  2013        PMID: 24286979     DOI: 10.1093/ndt/gft441

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  Statins and acute kidney injury following cardiac surgery: has the last word been told?

Authors:  Stefano Romagnoli; Zaccaria Ricci
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

2.  Hypoalbuminemia: a risk factor for acute kidney injury development and progression to chronic kidney disease in critically ill patients.

Authors:  Min Shao; Shengyu Wang; Praveen Kolumam Parameswaran
Journal:  Int Urol Nephrol       Date:  2016-11-05       Impact factor: 2.370

3.  Effect of an intensive nutrition intervention of a high protein and low glycemic-index diet on weight of kidney transplant recipients: study protocol for a randomized clinical trial.

Authors:  Elis Forcellini Pedrollo; Bruna Bellincanta Nicoletto; Larissa Salomoni Carpes; Júlia de Melo Cardoso de Freitas; Julia Roberta Buboltz; Cristina Carra Forte; Andrea Carla Bauer; Roberto Ceratti Manfro; Gabriela Corrêa Souza; Cristiane Bauermann Leitão
Journal:  Trials       Date:  2017-09-06       Impact factor: 2.279

4.  Lack of Association between Low Cumulative Dose of Hydroxyethyl Starch and Acute Kidney Injury in Patients with Acute Ischemic Stroke.

Authors:  Soo Hyun Park; Tae Jung Kim; Hae Bong Jeong; Sang Bae Ko
Journal:  J Korean Med Sci       Date:  2020-10-19       Impact factor: 2.153

Review 5.  Emperor's syndrome in the COVID-19 era: Time for patient-centered nephrology?

Authors:  Dimitra Bacharaki; Athanasios Diamandopoulos
Journal:  World J Nephrol       Date:  2021-01-25

6.  Calcium Repletion and Regional Citrate Anticoagulation in Hemodialysis and Hemodiafiltration: Using Dialysate Calcium to Modify Hypocalcemia.

Authors:  Justin R Dorie; Christopher W McIntyre; Sandrine Lemoine
Journal:  Kidney Med       Date:  2021-07-15

7.  Postoperative anemia is a risk factor for acute kidney injury after open aorta and vena cava surgeries.

Authors:  Rui Cui; Fangda Li; Jiang Shao; Yuzhu Wang; Cai Yue; Yuehong Zheng; Xuemei Li
Journal:  PLoS One       Date:  2020-10-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.